BioCentury
ARTICLE | Clinical News

NeoTherapeutics completes Phase IIb

April 5, 2000 7:00 AM UTC

NEOT said it completed enrollment of a U.S. Phase IIb trial of its Neotrofin AIT-082 leteprinim potassium in 440 patients with mild to moderate Alzheimer's disease. The company expects results to be a...